| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
HANDOK Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩13,390.00 |
| 52 Week High | ₩15,600.00 |
| 52 Week Low | ₩11,480.00 |
| Beta | 0.71 |
| 1 Month Change | -7.34% |
| 3 Month Change | 1.83% |
| 1 Year Change | -11.27% |
| 3 Year Change | -54.92% |
| 5 Year Change | -56.88% |
| Change since IPO | 1,133.39% |
Recent News & Updates
Recent updates
Is HANDOK Inc.'s (KRX:002390) 1.0% Dividend Worth Your Time?
Apr 01
How Much Of HANDOK Inc. (KRX:002390) Do Insiders Own?
Mar 15HANDOK (KRX:002390) Has A Somewhat Strained Balance Sheet
Feb 28Did You Miss HANDOK's (KRX:002390) 21% Share Price Gain?
Feb 13HANDOK Inc. (KRX:002390) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Jan 31We're Not So Sure You Should Rely on HANDOK's (KRX:002390) Statutory Earnings
Jan 18Here's Why I Think HANDOK (KRX:002390) Might Deserve Your Attention Today
Jan 05
Should HANDOK Inc. (KRX:002390) Be Part Of Your Dividend Portfolio?
Dec 23What Kind Of Investors Own Most Of HANDOK Inc. (KRX:002390)?
Dec 10HANDOK (KRX:002390) Has A Somewhat Strained Balance Sheet
Nov 27Shareholder Returns
| A002390 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 3.2% | 3.9% | 0.5% |
| 1Y | -11.3% | 8.3% | 4.7% |
Return vs Industry: A002390 underperformed the KR Pharmaceuticals industry which returned 8.3% over the past year.
Return vs Market: A002390 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A002390 volatility | |
|---|---|
| A002390 Average Weekly Movement | 3.5% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A002390 has not had significant price volatility in the past 3 months.
Volatility Over Time: A002390's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 937 | Young-Jin Kim | www.handok.co.kr |
HANDOK Inc. operates as a pharmaceutical company. The company provides ETC and OTC drugs; and medical devices and research products, including blood pressure monitors, cholesterol monitoring systems, insulin pumps, self monitoring system of blood glucose, and blood glucose monitoring system. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS, orphan diseases, eye disorders, and other disease areas.
HANDOK Inc. Fundamentals Summary
| A002390 fundamental statistics | |
|---|---|
| Market cap | ₩184.29b |
| Earnings (TTM) | -₩28.80b |
| Revenue (TTM) | ₩522.74b |
0.4x
P/S Ratio-6.4x
P/E RatioIs A002390 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A002390 income statement (TTM) | |
|---|---|
| Revenue | ₩522.74b |
| Cost of Revenue | ₩356.39b |
| Gross Profit | ₩166.35b |
| Other Expenses | ₩195.15b |
| Earnings | -₩28.80b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.09k |
| Gross Margin | 31.82% |
| Net Profit Margin | -5.51% |
| Debt/Equity Ratio | 87.6% |
How did A002390 perform over the long term?
See historical performance and comparison